Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained low-density lipoprotein-cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting.
Sánchez-Bacaicoa C, Galán J, Guijarro C, Rico-Martín S, Monreal M, Calderón-García JF, Aguilar-Cortés E, Sánchez Muñoz-Torrero JF; for FRENA Investigators. Sánchez-Bacaicoa C, et al. Among authors: guijarro c. Eur J Clin Invest. 2022 May;52(5):e13732. doi: 10.1111/eci.13732. Epub 2021 Dec 21. Eur J Clin Invest. 2022. PMID: 34908162
Validation of the QMon-20 oscillometric blood pressure monitor for professional office use in the general population according to the ANSI/ESH/ISO 81060-2:2018 protocol.
Rico-Martín S, Sánchez-Bacaicoa M, Calderón-García JF, Labrador-Gómez PJ, De Nicolás Jiménez JM, Villa-Rincón J, Robles NR, Guijarro C, Iammarino C, Rodilla-Salas E, Sánchez Muñoz-Torrero JF. Rico-Martín S, et al. Among authors: guijarro c. Blood Press Monit. 2021 Oct 1;26(5):393-395. doi: 10.1097/MBP.0000000000000540. Blood Press Monit. 2021. PMID: 34001760
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, Muñiz-Grijalvo O, Mediavilla JD, Argüeso R, Sánchez Muñoz-Torrero JF, Rubio P, Álvarez-Baños P, Ponte P, Mañas D, Suárez Gutierrez L, Cepeda JM, Casañas M, Fuentes F, Guijarro C, Ángel Barba M, Saltijeral Cerezo A, Padró T, Mata P; SAFEHEART Study Group. Pérez de Isla L, et al. Among authors: guijarro c. Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3. Circulation. 2023. PMID: 37009731 Free PMC article.
Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease.
Pedro-Botet J, López-Miranda J, Badimón L, Civeira F, Guijarro C, Millán J, Mostaza JM, Pintó X, Valdivielso P, Masana L; Expert group from the Spanish Arteriosclerosis Society. Pedro-Botet J, et al. Among authors: guijarro c. Am J Cardiovasc Drugs. 2020 Aug;20(4):325-332. doi: 10.1007/s40256-019-00376-y. Am J Cardiovasc Drugs. 2020. PMID: 31650523 Review.
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU).
Masana L, López Miranda J, Civeira F, Reinares L, Guijarro C, Plana N, Cuenca R, Sánchez D, Hernández JL, Andrés R, Blanco A, Villamayor S. Masana L, et al. Among authors: guijarro c. Clin Investig Arterioscler. 2020 Sep-Oct;32(5):183-192. doi: 10.1016/j.arteri.2020.02.003. Epub 2020 Apr 18. Clin Investig Arterioscler. 2020. PMID: 32317124 Free article. English, Spanish.
COVID-19 and cardiovascular disease.
Guijarro C. Guijarro C. Clin Investig Arterioscler. 2020 Nov-Dec;32(6):263-266. doi: 10.1016/j.arteri.2020.10.005. Clin Investig Arterioscler. 2020. PMID: 33213825 Free PMC article. English, Spanish. No abstract available.
155 results